Investing.com - Novartis ADR reported on Tuesday first quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Novartis ADR announced earnings per share of $1.46 on revenue of $12.53B. Analysts polled by Investing.com anticipated EPS of $1.44 on revenue of $12.6B.
Novartis ADR shares are up 3.4% from the beginning of the year, still down 4.97% from its 52 week high of $95.17 set on August 17, 2021. They are outperforming the EUR/USD which is down 0% from the start of the year.
Novartis ADR follows other major Healthcare sector earnings this month
Novartis ADR's report follows an earnings beat by UnitedHealth on April 14, who reported EPS of $5.49 on revenue of $80.15B, compared to forecasts EPS of $5.36 on revenue of $78.73B.
J&J had beat expectations on April 19 with first quarter EPS of $2.67 on revenue of $23.43B, compared to forecast for EPS of $2.59 on revenue of $23.62B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar